首页|雷贝拉唑联合伊托必利治疗功能性消化不良的临床效果及安全性分析

雷贝拉唑联合伊托必利治疗功能性消化不良的临床效果及安全性分析

扫码查看
目的 研究在功能性消化不良治疗中应用雷贝拉唑联合伊托必利治疗的效果和安全性.方法 选取2021年1月—2021年12月襄阳职业技术学院附属医院收治的90例功能性消化不良患者作为研究对象,采用摸球法将患者分为两组,每组45例.研究组实施雷贝拉唑联合伊托必利治疗,参考组实施伊托必利治疗.比较两组患者的治疗效果、症状积分、胃肠激素、不良反应、复发率.结果 研究组治疗有效率为97.78%,高于参考组的84.44%,差异有统计学意义(χ2=4.939,P<0.05);治疗后,研究组的症状积分低于参考组,胃肠激素指标优于参考组,复发率明显低于参考组,差异有统计学意义(P均<0.05).两组患者的不良反应发生率对比,差异无统计学意义(P>0.05).结论 给予功能性消化不良患者雷贝拉唑联合伊托必利治疗,可以提高治疗效果,缓解临床症状,改善胃肠激素水平,还有助于保障安全性,对于降低复发率也有着积极影响.
Clinical Analysis of Efficacy and Safety of Rabeprazole Combined with Ito-pride in the Treatment of Functional Dyspepsia
Objective To study the efficacy and safety of rabeprazole combined with itopride in the treatment of func-tional dyspepsia.Methods A total of 90 patients with functional dyspepsia admitted to the Affiliated Hospital of Xiangyang Vocational and Technical College from January 2021 to December 2021 were selected as the study objects,and the patients were divided into two groups with 45 cases in each group by touch ball method.The study group was treated with rabeprazole combined with itopride,the reference group was treated with itopride.The therapeutic effect,symptom score,gastrointestinal hormone,adverse reaction and recurrence rate were compared between the two groups of patients.Results The effective rate of the study group was 97.78%,higher than that of the reference group(84.44%),and the difference was statistically significant(χ2=4.939,P<0.05).After treatment,the symptom score of the study group was lower than that of the reference group,the gastrointestinal hormone index was better than that of the reference group,and the recurrence rate was significantly lower than that of the reference group,and the differences were statistically significant(all P<0.05).There was no significant difference in the incidence of adverse reactions be-tween the two groups(P>0.05).Conclusion The treatment of rabeprazole combined with itopride in patients with func-tional dyspepsia can improve the therapeutic effect,alleviate clinical symptoms,improve gastrointestinal hormone lev-els,and contribute to the guarantee of safety,which also has a positive impact on the reduction of recurrence rate.

Functional dyspepsiaRabeprazoleItopride

杨拓、何媛媛

展开 >

襄阳职业技术学院附属医院内科,湖北襄阳 441021

功能性消化不良 雷贝拉唑 伊托必利

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(6)
  • 13